DEFINITIVE PROXY

Company

CNS Pharmaceuticals, Inc.

Filed

April 24, 2020

Period of Report

May 7, 2020

Accession Number

0001683168-20-001282

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →